International Biotechnology Trust PLC Fulcrum Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.92 - $9.1 $948,536 - $1.75 Million	192,792 Added 20315.28%	193,741 $1.56 Million
Q2 2022 Aug 16, 2022	SELL	$4.2 - $24.0 $343,526 - $1.96 Million	-81,792 Reduced 98.85%	949 $194 Million
Q1 2022 May 20, 2022	BUY	$9.96 - $23.65 $216,540 - $514,174	21,741 Added 35.64%	82,741 $1.96 Million
Q4 2021 Feb 15, 2022	BUY	$14.0 - $28.44 $854,000 - $1.73 Million	61,000 New	61,000 $1.08 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.